Sign In
Buy CSBR
$5.69
-0.0350 (-0.611%)
At Close: Jun 03, 2026
Champions Oncology Reports Quarterly Revenue of $10.6 Million
08:00am, Thursday, 22'nd Jul 2021
Record Annual Revenue of $41 Million HACKENSACK, NJ / ACCESSWIRE / July 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in creating transformative technology solutions to be utilized in dru
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
08:30am, Wednesday, 14'th Jul 2021
HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative
HACKENSACK, NJ / ACCESSWIRE / June 15, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced today that they have entered into a strategic partnership with BGI
7 Micro-Cap Stocks to Buy That Are Shining Right Now
12:22pm, Friday, 02'nd Apr 2021
The markets keep going up as new stimulus spending and the massive new infrastructure bill hit. These micro-cap stocks are bargains.
Strength Seen in Champions Oncology, Inc. (CSBR): Can Its 15.3% Jump Turn into More Strength?
12:07pm, Tuesday, 16'th Mar 2021
Champions Oncology, Inc. (CSBR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in t
Champions Oncology Reports Record Quarterly Revenue of $10.8 Million
04:00pm, Thursday, 11'th Mar 2021
HACKENSACK, NJ / ACCESSWIRE / March 11, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery and development th
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021
08:30am, Friday, 05'th Mar 2021
HACKENSACK, NJ / ACCESSWIRE / March 5, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative
Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics
09:00am, Tuesday, 19'th Jan 2021
HACKENSACK, NJ / ACCESSWIRE / January 19, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-
HACKENSACK, NJ / ACCESSWIRE / January 5, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-dr
Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q1 2021 Results - Earnings Call Transcript
06:20pm, Monday, 14'th Sep 2020
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2021 Earnings Conference Call September 14, 2020 04:30 PM ET Company Participants Ronnie Morris - President and CEO David Miller - Chief Financial Officer Con
Champions Oncology, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
11:21am, Thursday, 30'th Jul 2020
There's been a notable change in appetite for Champions Oncology, Inc. (NASDAQ:CSBR) shares in the week since its...
Champions Oncology Reports Quarterly Revenue of $8.8 Million
08:01pm, Monday, 27'th Jul 2020
Record Annual Revenue of $32.
Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q4 2020 Results - Earnings Call Transcript
07:24pm, Monday, 27'th Jul 2020
Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2020 Results Earnings Conference Call July 27, 2020, 4:30 pm ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Of
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020
12:00pm, Wednesday, 22'nd Jul 2020
HACKENSACK, NJ / ACCESSWIRE / July 22, 2020 / Champions Oncology, Inc.
